PENTIXAPHARM HOLDING N AG (XETRA:PTP) — Stock Price
PENTIXAPHARM HOLDING N AG (XETRA:PTP) is currently trading at €1.85 EUR, up 0.54% today. Over the past 52 weeks, shares have ranged between €1.36 and €2.85. This page tracks PENTIXAPHARM HOLDING N AG's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see PTP operating cash flow.
PENTIXAPHARM HOLDING N AG (PTP) Stock Price Chart — Daily History & Trading Volume
The chart below tracks PENTIXAPHARM HOLDING N AG's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.
PENTIXAPHARM HOLDING N AG Income Statement — Revenue, Profit & Earnings by Year
PENTIXAPHARM HOLDING N AG's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €93.00K | €118.00K | €24.00K | €31.00K | €59.00K |
| Cost of Revenue | €6.80 Million | €3.72 Million | €-4.70 Million | €-3.94 Million | €-2.54 Million |
| Gross Profit | €-6.70 Million | €-3.60 Million | €4.72 Million | €3.97 Million | €2.60 Million |
| Research & Development | €205.00K | — | €8.31 Million | €4.35 Million | €2.89 Million |
| SG&A | €1.02 Million | €472.00K | €1.79 Million | €428.00K | €117.00K |
| Total Operating Expenses | €19.68 Million | €17.70 Million | €6.18 Million | €2.21 Million | €1.70 Million |
| Operating Income | €-19.59 Million | €-17.58 Million | €-6.16 Million | €-2.18 Million | €-1.64 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €0.00 | €53.00K | €183.00K | €0.00 | €1.00K |
| Income Before Tax | €-19.51 Million | €-16.55 Million | €-6.21 Million | €-779.00K | €-1.73 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-16.51 Million | €-12.84 Million | €-7.64 Million | €-1.96 Million | €-2.49 Million |
PENTIXAPHARM HOLDING N AG Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes PENTIXAPHARM HOLDING N AG's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €41.86 Million | €67.39 Million | €73.40 Million | €53.88 Million | €29.15 Million |
| Total Current Assets | €5.99 Million | €31.28 Million | €18.71 Million | €3.85 Million | €2.56 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €342.00K | — | €531.00K | — | — |
| Net Receivables | €31.00K | €6.80 Million | €159.00K | €512.00K | €12.00K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €0.00 | €0.00 | €775.00K | €775.00K | €0.00 |
| Total Liabilities | €6.79 Million | €17.97 Million | €24.92 Million | €15.41 Million | €1.26 Million |
| Total Current Liabilities | €3.46 Million | €14.04 Million | €9.40 Million | €1.84 Million | €502.00K |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €35.07 Million | €49.41 Million | €48.48 Million | €38.47 Million | €27.88 Million |
| Retained Earnings | €-28.44 Million | €-12.84 Million | €2.13 Million | €-298.00K | €-4.45 Million |
PENTIXAPHARM HOLDING N AG Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how PENTIXAPHARM HOLDING N AG generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-17.97 Million | €-4.33 Million | €2.13 Million | €-2.20 Million | €-1.37 Million |
| Capital Expenditures | €625.00K | €1.00K | €4.94 Million | €4.05 Million | €2.73 Million |
| Free Cash Flow | €-18.60 Million | €-4.33 Million | €-2.81 Million | €-6.24 Million | €-4.10 Million |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €3.73 Million | €19.04 Million | — | — | — |
| Change in Cash | €-18.61 Million | €23.18 Million | — | — | — |
PENTIXAPHARM HOLDING N AG Earnings History — EPS Actual vs. Analyst Estimates
Track PENTIXAPHARM HOLDING N AG's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jun 30, 2026 | -0.14 | — | — |
| Mar 31, 2026 | -0.12 | — | — |
| Sep 30, 2025 | -0.16 | — | — |
| Jun 30, 2025 | -0.17 | — | — |
| Mar 31, 2025 | -0.15 | — | — |